 | • レポートコード：QY2108PAL8790 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるセレコキシブの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、セレコキシブの種類別市場規模（50mg、100mg、200mg、400mg）、用途別市場規模（関節リウマチ、変形性関節症、急性痛、筋骨格痛、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のセレコキシブ市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるセレコキシブの種類別市場規模（2016年-2027年）：50mg、100mg、200mg、400mg ・世界におけるセレコキシブの用途別市場規模（2016年-2027年）：関節リウマチ、変形性関節症、急性痛、筋骨格痛、その他 ・セレコキシブの中国市場分析 - セレコキシブの中国市場規模（2016年-2027年） - 中国におけるセレコキシブの主要プレイヤー別市場シェア - 中国におけるセレコキシブの種類別市場規模：50mg、100mg、200mg、400mg - 中国におけるセレコキシブの用途別市場規模：関節リウマチ、変形性関節症、急性痛、筋骨格痛、その他 ・セレコキシブの北米市場（2016年-2027年） ・セレコキシブのヨーロッパ市場（2016年-2027年） ・セレコキシブのアジア太平洋市場（2016年-2027年） ・セレコキシブの中南米市場（2016年-2027年） ・セレコキシブの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Pfizer Inc、Teva、Mylan、Apotex、Lupin、Hengrui Medicine ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
Market Analysis and Insights: Global and China Celecoxib Market
This report focuses on global and China Celecoxib market.
In 2020, the global Celecoxib market size was US$ 1175.4 million and it is expected to reach US$ 2062.6 million by the end of 2027, with a CAGR of 8.4% during 2021-2027. In China the Celecoxib market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Celecoxib Scope and Market Size
Celecoxib market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Celecoxib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Celecoxib market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
50mg
100mg
200mg
400mg
Segment by Application
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
1 Study Coverage
1.1 Celecoxib Product Introduction
1.2 Market by Type
1.2.1 Global Celecoxib Market Size Growth Rate by Type
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Celecoxib Market Size Growth Rate by Application
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Celecoxib Market Size, Estimates and Forecasts
2.1.1 Global Celecoxib Revenue 2016-2027
2.1.2 Global Celecoxib Sales 2016-2027
2.2 Global Celecoxib, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Celecoxib Historical Market Size by Region (2016-2021)
2.3.1 Global Celecoxib Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Celecoxib Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Celecoxib Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Celecoxib Sales Forecast by Region (2022-2027)
2.4.2 Global Celecoxib Revenue Forecast by Region (2022-2027)
3 Global Celecoxib Competitor Landscape by Players
3.1 Global Top Celecoxib Manufacturers by Sales
3.1.1 Global Celecoxib Sales by Manufacturer (2016-2021)
3.1.2 Global Celecoxib Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Celecoxib Manufacturers by Revenue
3.2.1 Key Celecoxib Manufacturers Covered: Ranking by Revenue
3.2.2 Global Celecoxib Revenue by Manufacturers (2016-2021)
3.2.3 Global Celecoxib Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Celecoxib Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Celecoxib Revenue in 2020
3.2.6 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Celecoxib Price by Manufacturers
3.4 Global Celecoxib Manufacturing Base Distribution, Product Types
3.4.1 Celecoxib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Celecoxib Product Type
3.4.3 Date of International Manufacturers Enter into Celecoxib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Celecoxib Market Size by Type (2016-2021)
4.1.1 Global Celecoxib Sales by Type (2016-2021)
4.1.2 Global Celecoxib Revenue by Type (2016-2021)
4.1.3 Celecoxib Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Celecoxib Market Size Forecast by Type (2022-2027)
4.2.1 Global Celecoxib Sales Forecast by Type (2022-2027)
4.2.2 Global Celecoxib Revenue Forecast by Type (2022-2027)
4.2.3 Celecoxib Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Celecoxib Market Size by Application (2016-2021)
5.1.1 Global Celecoxib Sales by Application (2016-2021)
5.1.2 Global Celecoxib Revenue by Application (2016-2021)
5.1.3 Celecoxib Price by Application (2016-2021)
5.2 Celecoxib Market Size Forecast by Application (2022-2027)
5.2.1 Global Celecoxib Sales Forecast by Application (2022-2027)
5.2.2 Global Celecoxib Revenue Forecast by Application (2022-2027)
5.2.3 Global Celecoxib Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Celecoxib Market Size YoY Growth 2016-2027
6.1.1 China Celecoxib Sales YoY Growth 2016-2027
6.1.2 China Celecoxib Revenue YoY Growth 2016-2027
6.1.3 China Celecoxib Market Share in Global Market 2016-2027
6.2 China Celecoxib Market Size by Players (International and Local Players)
6.2.1 China Top Celecoxib Players by Sales (2016-2021)
6.2.2 China Top Celecoxib Players by Revenue (2016-2021)
6.3 China Celecoxib Historic Market Review by Type (2016-2021)
6.3.1 China Celecoxib Sales Market Share by Type (2016-2021)
6.3.2 China Celecoxib Revenue Market Share by Type (2016-2021)
6.3.3 China Celecoxib Price by Type (2016-2021)
6.4 China Celecoxib Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Celecoxib Sales Forecast by Type (2022-2027)
6.4.2 China Celecoxib Revenue Forecast by Type (2022-2027)
6.4.3 China Celecoxib Price Forecast by Type (2022-2027)
6.5 China Celecoxib Historic Market Review by Application (2016-2021)
6.5.1 China Celecoxib Sales Market Share by Application (2016-2021)
6.5.2 China Celecoxib Revenue Market Share by Application (2016-2021)
6.5.3 China Celecoxib Price by Application (2016-2021)
6.6 China Celecoxib Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Celecoxib Sales Forecast by Application (2022-2027)
6.6.2 China Celecoxib Revenue Forecast by Application (2022-2027)
6.6.3 China Celecoxib Price Forecast by Application (2022-2027)
7 North America
7.1 North America Celecoxib Market Size YoY Growth 2016-2027
7.2 North America Celecoxib Market Facts & Figures by Country
7.2.1 North America Celecoxib Sales by Country (2016-2021)
7.2.2 North America Celecoxib Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Celecoxib Market Size YoY Growth 2016-2027
8.2 Asia Pacific Celecoxib Market Facts & Figures by Region
8.2.1 Asia Pacific Celecoxib Sales by Region (2016-2021)
8.2.2 Asia Pacific Celecoxib Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Celecoxib Market Size YoY Growth 2016-2027
9.2 Europe Celecoxib Market Facts & Figures by Country
9.2.1 Europe Celecoxib Sales by Country (2016-2021)
9.2.2 Europe Celecoxib Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Celecoxib Market Size YoY Growth 2016-2027
10.2 Latin America Celecoxib Market Facts & Figures by Country
10.2.1 Latin America Celecoxib Sales by Country (2016-2021)
10.2.2 Latin America Celecoxib Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Celecoxib Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Celecoxib Market Facts & Figures by Country
11.2.1 Middle East and Africa Celecoxib Sales by Country (2016-2021)
11.2.2 Middle East and Africa Celecoxib Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer Inc
12.1.1 Pfizer Inc Corporation Information
12.1.2 Pfizer Inc Description and Business Overview
12.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Inc Celecoxib Products Offered
12.1.5 Pfizer Inc Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Celecoxib Products Offered
12.2.5 Teva Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Description and Business Overview
12.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Celecoxib Products Offered
12.3.5 Mylan Recent Development
12.4 Apotex
12.4.1 Apotex Corporation Information
12.4.2 Apotex Description and Business Overview
12.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Apotex Celecoxib Products Offered
12.4.5 Apotex Recent Development
12.5 Lupin
12.5.1 Lupin Corporation Information
12.5.2 Lupin Description and Business Overview
12.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lupin Celecoxib Products Offered
12.5.5 Lupin Recent Development
12.6 Hengrui Medicine
12.6.1 Hengrui Medicine Corporation Information
12.6.2 Hengrui Medicine Description and Business Overview
12.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hengrui Medicine Celecoxib Products Offered
12.6.5 Hengrui Medicine Recent Development
12.11 Pfizer Inc
12.11.1 Pfizer Inc Corporation Information
12.11.2 Pfizer Inc Description and Business Overview
12.11.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Inc Celecoxib Products Offered
12.11.5 Pfizer Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Celecoxib Industry Trends
13.2 Celecoxib Market Drivers
13.3 Celecoxib Market Challenges
13.4 Celecoxib Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Celecoxib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Celecoxib Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 50mg
Table 3. Major Manufacturers of 100mg
Table 4. Major Manufacturers of 200mg
Table 5. Major Manufacturers of 400mg
Table 6. Global Celecoxib Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Celecoxib Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Celecoxib Sales by Regions (2016-2021) & (K Units)
Table 9. Global Celecoxib Sales Market Share by Regions (2016-2021)
Table 10. Global Celecoxib Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Celecoxib Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Celecoxib Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Celecoxib Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Celecoxib Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Celecoxib Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Celecoxib Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Celecoxib Manufacturers by Revenue (US$ Million) in 2020
Table 18. Celecoxib Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Celecoxib Revenue Share by Manufacturers (2016-2021)
Table 20. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Celecoxib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celecoxib as of 2020)
Table 22. Key Manufacturers Celecoxib Price (2016-2021) (US$/Unit)
Table 23. Celecoxib Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Celecoxib Product Type
Table 25. Date of International Manufacturers Enter into Celecoxib Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Celecoxib Sales by Type (2016-2021) (K Units)
Table 28. Global Celecoxib Sales Share by Type (2016-2021)
Table 29. Global Celecoxib Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Celecoxib Revenue Share by Type (2016-2021)
Table 31. Celecoxib Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 32. Global Celecoxib Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Celecoxib Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Celecoxib Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Celecoxib Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Celecoxib Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Celecoxib Sales by Application (2016-2021) (K Units)
Table 38. Global Celecoxib Sales Share by Application (2016-2021)
Table 39. Global Celecoxib Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Celecoxib Revenue Share by Application (2016-2021)
Table 41. Celecoxib Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 42. Global Celecoxib Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Celecoxib Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Celecoxib Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Celecoxib Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Celecoxib Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 47. China Celecoxib Sales (K Units) of Key Companies (2016-2021)
Table 48. China Celecoxib Sales Share by Company (2016-2021)
Table 49. China Celecoxib Revenue (US$ Million) by Company (2016-2021)
Table 50. China Celecoxib Revenue Share by Company (2016-2021)
Table 51. China Celecoxib Sales (K Units) by Type (2016-2021)
Table 52. China Celecoxib Sales Share by Type (2016-2021)
Table 53. China Celecoxib Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Celecoxib Price (US$/Unit) by Type (2016-2021)
Table 55. China Celecoxib Sales (K Units) by Type (2022-2027)
Table 56. China Celecoxib Sales Share by Type (2022-2027)
Table 57. China Celecoxib Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Celecoxib Revenue Share by Type (2022-2027)
Table 59. China Celecoxib Price (US$/Unit) by Type (2022-2027)
Table 60. China Celecoxib Sales (K Units) by Application (2016-2021)
Table 61. China Celecoxib Sales Share by Application (2016-2021)
Table 62. China Celecoxib Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Celecoxib Price (US$/Unit) by Application (2016-2021)
Table 64. China Celecoxib Sales (K Units) by Application (2022-2027)
Table 65. China Celecoxib Sales Share by Application (2022-2027)
Table 66. China Celecoxib Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Celecoxib Revenue Share by Application (2022-2027)
Table 68. China Celecoxib Price (US$/Unit) by Application (2022-2027)
Table 69. North America Celecoxib Sales by Country (2016-2021) & (K Units)
Table 70. North America Celecoxib Sales Market Share by Country (2016-2021)
Table 71. North America Celecoxib Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Celecoxib Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Celecoxib Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Celecoxib Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Celecoxib Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Celecoxib Revenue Market Share by Region (2016-2021)
Table 77. Europe Celecoxib Sales by Country (2016-2021) & (K Units)
Table 78. Europe Celecoxib Sales Market Share by Country (2016-2021)
Table 79. Europe Celecoxib Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Celecoxib Revenue Market Share by Country (2016-2021)
Table 81. Latin America Celecoxib Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Celecoxib Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Celecoxib Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Celecoxib Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Celecoxib Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Celecoxib Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Celecoxib Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Celecoxib Revenue Market Share by Country (2016-2021)
Table 89. Pfizer Inc Corporation Information
Table 90. Pfizer Inc Description and Business Overview
Table 91. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 92. Pfizer Inc Celecoxib Product
Table 93. Pfizer Inc Recent Development
Table 94. Teva Corporation Information
Table 95. Teva Description and Business Overview
Table 96. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. Teva Product
Table 98. Teva Recent Development
Table 99. Mylan Corporation Information
Table 100. Mylan Description and Business Overview
Table 101. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 102. Mylan Product
Table 103. Mylan Recent Development
Table 104. Apotex Corporation Information
Table 105. Apotex Description and Business Overview
Table 106. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 107. Apotex Product
Table 108. Apotex Recent Development
Table 109. Lupin Corporation Information
Table 110. Lupin Description and Business Overview
Table 111. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. Lupin Product
Table 113. Lupin Recent Development
Table 114. Hengrui Medicine Corporation Information
Table 115. Hengrui Medicine Description and Business Overview
Table 116. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. Hengrui Medicine Product
Table 118. Hengrui Medicine Recent Development
Table 119. Celecoxib Market Trends
Table 120. Celecoxib Market Drivers
Table 121. Celecoxib Market Challenges
Table 122. Celecoxib Market Restraints
Table 123. Celecoxib Customers List
Table 124. Celecoxib Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Celecoxib Product Picture
Figure 2. Global Celecoxib Sales Market Share by Type in 2020 & 2027
Figure 3. 50mg Product Picture
Figure 4. 100mg Product Picture
Figure 5. 200mg Product Picture
Figure 6. 400mg Product Picture
Figure 7. Global Celecoxib Sales Market Share by Application in 2020 & 2027
Figure 8. Rheumatoid arthritis
Figure 9. osteoarthritis
Figure 10. Acute pain
Figure 11. Musculoskeletal pain
Figure 12. Other diseases
Figure 13. Celecoxib Report Years Considered
Figure 14. Global Celecoxib Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Celecoxib Market Size 2016-2027 (US$ Million)
Figure 16. Global Celecoxib Sales 2016-2027 (K Units)
Figure 17. Global Celecoxib Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Celecoxib Sales Market Share by Region (2016-2021)
Figure 19. Global Celecoxib Sales Market Share by Region in 2020
Figure 20. Global Celecoxib Revenue Market Share by Region (2016-2021)
Figure 21. Global Celecoxib Revenue Market Share by Region in 2020
Figure 22. Global Celecoxib Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Celecoxib Revenue in 2020
Figure 24. Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Celecoxib Sales Market Share by Type (2016-2021)
Figure 26. Global Celecoxib Sales Market Share by Type in 2020
Figure 27. Global Celecoxib Revenue Market Share by Type (2016-2021)
Figure 28. Global Celecoxib Revenue Market Share by Type in 2020
Figure 29. Global Celecoxib Sales Market Share by Application (2016-2021)
Figure 30. Global Celecoxib Sales Market Share by Application in 2020
Figure 31. Global Celecoxib Revenue Market Share by Application (2016-2021)
Figure 32. Global Celecoxib Revenue Market Share by Application in 2020
Figure 33. China Celecoxib Sales Growth Rate 2016-2027 (K Units)
Figure 34. China Celecoxib Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. China Celecoxib Market Share in Global Market 2016-2027
Figure 36. China 5 and 10 Largest Celecoxib Players Market Share by Revenue in Celecoxib in 2020
Figure 37. China Celecoxib Revenue Share by Type (2016-2021)
Figure 38. China Celecoxib Revenue Growth Rate by Type in 2016 & 2020
Figure 39. China Celecoxib Revenue Share by Application (2016-2021)
Figure 40. China Celecoxib Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Celecoxib Sales Growth Rate 2016-2021 (K Units)
Figure 42. North America Celecoxib Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Celecoxib Sales Market Share by Country in 2020
Figure 44. North America Celecoxib Revenue Market Share by Country in 2020
Figure 45. U.S. Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 46. U.S. Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 48. Canada Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Celecoxib Sales Growth Rate 2016-2021 (K Units)
Figure 50. Europe Celecoxib Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Celecoxib Sales Market Share by Country in 2020
Figure 52. Europe Celecoxib Revenue Market Share by Country in 2020
Figure 53. Germany Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 54. Germany Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 56. France Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 58. U.K. Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 60. Italy Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 62. Russia Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Celecoxib Sales Growth Rate 2016-2021 (K Units)
Figure 64. Asia Pacific Celecoxib Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Celecoxib Sales Market Share by Region in 2020
Figure 66. Asia Pacific Celecoxib Revenue Market Share by Region in 2020
Figure 67. China Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 68. China Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 70. Japan Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 72. South Korea Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 74. India Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 76. Australia Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 78. Taiwan Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 80. Indonesia Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 82. Thailand Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 84. Malaysia Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 86. Philippines Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 88. Vietnam Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Celecoxib Sales Growth Rate 2016-2021 (K Units)
Figure 90. Latin America Celecoxib Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Celecoxib Sales Market Share by Country in 2020
Figure 92. Latin America Celecoxib Revenue Market Share by Country in 2020
Figure 93. Mexico Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 94. Mexico Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 96. Brazil Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 98. Argentina Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa Celecoxib Sales Growth Rate 2016-2021 (K Units)
Figure 100. Middle East and Africa Celecoxib Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa Celecoxib Sales Market Share by Country in 2020
Figure 102. Middle East and Africa Celecoxib Revenue Market Share by Country in 2020
Figure 103. Turkey Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 104. Turkey Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 106. Saudi Arabia Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. UAE Celecoxib Sales Growth Rate (2016-2021) (K Units)
Figure 108. UAE Celecoxib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Celecoxib Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
セレコキシブカプセルの世界市場 2020年 Market Overview The Celecoxib Capsule market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- セレコキシブの世界市場 2020年 Market Overview The Celecoxib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 変形性関節症鎮痛剤の世界市場 2020年 Market Overview The Osteoarthritis Pain Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 変形性関節症苦痛治療薬の世界市場 2020年 Market Overview The Drugs for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 変形性関節症疼痛の世界市場 2020年 Market Overview The global Osteoarthritis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis Pain marke…